Norges Bank’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-416,237
Closed -$3.08M 816
2024
Q4
$3.08M Buy
+416,237
New +$3.08M ﹤0.01% 1621
2024
Q3
Sell
-942,983
Closed -$7.56M 841
2024
Q2
$7.56M Sell
942,983
-149,004
-14% -$1.2M ﹤0.01% 1465
2024
Q1
$16.2M Sell
1,091,987
-28,470
-3% -$422K ﹤0.01% 1319
2023
Q4
$9.11M Hold
1,120,457
﹤0.01% 1519
2023
Q3
$5.1M Hold
1,120,457
﹤0.01% 1668
2023
Q2
$7.89M Sell
1,120,457
-1,319,600
-54% -$9.29M ﹤0.01% 1606
2023
Q1
$14.9M Sell
2,440,057
-534,800
-18% -$3.27M ﹤0.01% 1412
2022
Q4
$19M Buy
2,974,857
+1,578,500
+113% +$10.1M ﹤0.01% 1296
2022
Q3
$13.4M Buy
1,396,357
+42,122
+3% +$404K ﹤0.01% 1418
2022
Q2
$15M Buy
1,354,235
+496
+0% +$5.48K ﹤0.01% 1383
2022
Q1
$22.5M Buy
1,353,739
+52,289
+4% +$871K ﹤0.01% 1334
2021
Q4
$24.8M Buy
1,301,450
+63,252
+5% +$1.21M 0.01% 1357
2021
Q3
$30.5M Buy
1,238,198
+52,525
+4% +$1.3M 0.01% 1204
2021
Q2
$30.9M Sell
1,185,673
-38,743
-3% -$1.01M 0.01% 1257
2021
Q1
$38.8M Sell
1,224,416
-248,215
-17% -$7.86M 0.01% 1121
2020
Q4
$68.3M Sell
1,472,631
-57,523
-4% -$2.67M 0.02% 771
2020
Q3
$50.4M Buy
1,530,154
+80,375
+6% +$2.65M 0.01% 834
2020
Q2
$39.8M Buy
1,449,779
+140,800
+11% +$3.86M 0.01% 984
2020
Q1
$39.2M Hold
1,308,979
0.01% 824
2019
Q4
$36.2M Buy
1,308,979
+701,550
+115% +$19.4M 0.01% 1119
2019
Q3
$11.1M Buy
607,429
+587,429
+2,937% +$10.7M ﹤0.01% 1739
2019
Q2
$490K Hold
20,000
﹤0.01% 2058
2019
Q1
$190K Hold
20,000
﹤0.01% 2099
2018
Q4
$177K Buy
+20,000
New +$177K ﹤0.01% 2103